Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience
Anticancer Research · 2023
DOI: 10.21873/anticanres.16183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Ondrej Fiala und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic; fial…. Hauptthemen laut MEDLINE: Abiraterone Acetate, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic; fialao@fnplzen.cz.
- Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
- Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
- Department of Urology, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
- Department of Immunochemistry Diagnostics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
Zitieren
APA
Fiala, O., Hosek, P., Korunkova, H., Hora, M., Kolar, J., Windrichova, J., Sorejs, O., Topolcan, O., Travnicek, I., Sedlackova, H., & Finek, J. (2023). Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience. Anticancer Research. https://doi.org/10.21873/anticanres.16183
Vancouver
Fiala O, Hosek P, Korunkova H, Hora M, Kolar J, Windrichova J, et al. Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience. Anticancer Research. 2023. doi:10.21873/anticanres.16183
BibTeX
@article{Fiala2023,
author = {Fiala, Ondrej and Hosek, Petr and Korunkova, Hana and Hora, Milan and Kolar, Jiri and Windrichova, Jindra and Sorejs, Ondrej and Topolcan, Ondrej and Travnicek, Ivan and Sedlackova, Hana and Finek, Jindrich},
title = {Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16183}
}
EUVIMED